Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 30

Sort by

Sort Order Select

Journal Articles

Demonstration of the Safety of Post Induction Infusion of Ex-Vivo Expanded Cord Blood Progenitor Cells in Pediatric Patients with Relapsed/Refractory Acute Myelogenous Leukemia

Ann Dahlberg, MD, Muna Qayed, MDMSc, Katherine Tarlock, MD, Jessica A. Pollard, MD, Filippo Milano, MD PhD, Soheil Meshinchi, MD PhD, Colleen Delaney, MD MSc

Blood (2019) 134 (Supplement_1): 2614.

https://doi.org/10.1182/blood-2019-130979

Published: 2019

Journal Articles

Prophylactic Infusion of Multi-Antigen Specific T-Cell Products to Prevent Complications after T Cell Depleted Allogeneic Stem Cell Transplantation — a Phase I/II Study

Marthe C.J. Roex, MD, Peter van Balen, MD, Lothar Germeroth, PhD, Lois Hageman, Esther van Egmond, Sabrina A.J. Veld, Conny Hoogstraten, Ellis van Liempt, PhD, Jaap J. Zwaginga, MD PhD, Liesbeth C. de Wreede, PhD, Hermann Einsele, MD PhD, Hendrik Veelken, MD PhD, Constantijn J.M. Halkes, MD, Inge Jedema, PhD, J.H. Frederik Falkenburg, MD PhD

Blood (2018) 132 (Supplement 1): 119.

https://doi.org/10.1182/blood-2018-99-111749

Published: 2018

Journal Articles

Novel Von Willebrand Factor (vWF) Fragment Supports Subcutaneous Administration of Factor VIII: Pharmacokinetic Data from Hemophilia A Mouse Model

Nadine Vollack, PhD, Sonja Werwitzke, MD PhD, Barbara A Solecka-Witulska, PhD, Christoph Kannicht, PhD, Andreas Tiede, MD

Blood (2017) 130 (Supplement 1): 4877.

https://doi.org/10.1182/blood.V130.Suppl_1.4877.4877

Published: 2017

Journal Articles

A Novel Von Willebrand Factor Fragment Acts As a Chaperone to Prolong the Half-Life of Recombinant Human FVIII (Simoctocog Alfa) in Hemophilia a Dogs and FVIII/VWF Double Knockout Mice

Barbara A Solecka-Witulska, PhD, David Lillicrap, MD FRCPC, Christine Hough, PhD, Christoph Kannicht, PhD

Blood (2017) 130 (Supplement 1): 178.

https://doi.org/10.1182/blood.V130.Suppl_1.178.178

Published: 2017

Journal Articles

A Novel Method for Highly Sensitive Detection and Isolation of Chimeric Antigen Receptor and Cancer Associated Antigen-Expressing Cells

Blood (2017) 130 (Supplement 1): 1915.

https://doi.org/10.1182/blood.V130.Suppl_1.1915.1915

Published: 2017

Journal Articles

Pharmacokinetics of Subcutaneously Administered Simoctocog Alfa with Von Willebrand Factor Fragment Candidates in a Minipig Model

Barbara A Solecka-Witulska, PhD, Silvio Wuschko, PhD, Christoph Kannicht, PhD

Blood (2017) 130 (Supplement 1): 1073.

https://doi.org/10.1182/blood.V130.Suppl_1.1073.1073

Published: 2017

Journal Articles

Large-Scale, Bioreactor-Generated Expansion of Umbilical Cord Blood Tissue-Derived Mesenchymal Stromal Cells for Clinical Use

Blood (2017) 130 (Supplement 1): 3198.

https://doi.org/10.1182/blood.V130.Suppl_1.3198.3198

Published: 2017

Journal Articles

TALEN-mediated genetic inactivation of the glucocorticoid receptor in cytomegalovirus-specific T cells

Laurie Menger, Agnes Gouble, Maria A. V. Marzolini, Annette Pachnio, Katharina Bergerhoff, Jake Y. Henry, Julianne Smith, Martin Pule, Paul Moss, Stanley R. Riddell, Sergio A. Quezada, Karl S. Peggs

Blood (2015) 126 (26): 2781–2789.

https://doi.org/10.1182/blood-2015-08-664755

Published: 2015

Includes: Supplemental data

Journal Articles

Expanded Access Program of Graspa for Treatment of Patients with Acute Lymphoblastic Leukemia Unable to Receive Other Form of L-Asparaginase - a Status Update (NCT02197650)

Yves Bertrand, MDPhD, Hervé Dombret, Bruno Quesnel, MD PhD, Jean-Louis Stephan, MD, Claudine Schmitt, MD, Severine Lissandre, MD, Maryline Poiree, MD, Christian Recher, MDPhD, Emmanuel Plouvier, MD, Cécile Dumesnil de Maricourt, MD, David Salako, MSc, Yann Godfrin, PhD, Iman El Hariry, MDPhD

Blood (2015) 126 (23): 4877.

https://doi.org/10.1182/blood.V126.23.4877.4877

Published: 2015

Journal Articles

Tumor Associated Antigen Reactive Donor T Cells As Elementary Components of Streptamer Isolated Multi-Antigen Specific T Cells

Marthe C.J. Roex, MD, Ellis van Liempt, PhD, Lois Hageman, Lothar Germeroth, PhD, Constantijn J.M. Halkes, MD PhD, J.H. Frederik Falkenburg, MD PhD, Inge Jedema, PhD

Blood (2014) 124 (21): 313.

https://doi.org/10.1182/blood.V124.21.313.313

Published: 2014

Journal Articles

CMV~IMPACT: Results of a Randomized Controlled Trial of Immuno-Prophylactic Adoptive Cellular Therapy following Sibling Donor Allogeneic HSCT

Karl S Peggs, Eleni Tholouli, Ronjon Chakraverty, PhD, Emmanouil Nikolousis, PhD, Adrian Bloor, PhD FRCPath, Stephen Devereux, MD PhD FRCPath, Kim H. Orchard, PhD, Charles Crawley, Anne Parker, Stephen P Robinson, PhD, Frederick Chen, MDPhD, Gordon Cook, MD, Richard E Clark, MBBS MD, Kirsty Thomson, Matthew Cobb, Katy Newton, PhD, Simon Thomas, PhD, Paul Moss, PhD

Blood (2014) 124 (21): 1109.

https://doi.org/10.1182/blood.V124.21.1109.1109

Published: 2014

Journal Articles

The Impact of Donor HLA Type on Characteristics of CMV-Specific T Cell Products: Experience from Two UK Randomized Trials

Amanda Skulte, BSc, MClinTRes, Arindam Mitra, BSc, Simon Thomas, PhD, Matthew Cobb, Alka Stansfield, Karl S Peggs, Katy Newton, PhD

Blood (2014) 124 (21): 1124.

https://doi.org/10.1182/blood.V124.21.1124.1124

Published: 2014

Journal Articles

Influence Of Steroid Exposure On CMV Specific T Cells Following Allogeneic Stem Cell Transplantation

Cornelia S. Link, MD, Elke Rücker-Braun, PhD, Sebastian Tuve, MD, Sarah Matko, Marc Schmitz, MD, Rebekka Wehner, PhD, Antje Tunger, Katja Sockel, MD, Stefani Parmentier, MD, Jan Moritz Middeke, MD, Änne Boldt, MD, Johannes Schetelig, MD, M. Sc,, Markus Odendahl, PhD, Torsten Tonn, MD, Martin Bornhäuser, MD, Falk Heidenreich, PhD

Blood (2013) 122 (21): 5488.

https://doi.org/10.1182/blood.V122.21.5488.5488

Published: 2013

Journal Articles

Geminin Is a Newly Identified Cks1 Interaction Partner and Overexpressed in a Murine Model During Lymphomagenesis

Alexander Hoellein, MD, Florian Bassermann, Stephanie Schoeffmann, Steffi Graf, Christian Peschel, MD, Johannes Gloeckner, PhD, Marius Ueffing, PhD, Ulrich Keller, MD

Blood (2012) 120 (21): 1328.

https://doi.org/10.1182/blood.V120.21.1328.1328

Published: 2012

Journal Articles

Infectious Complications in Pediatric Patients with AML Demonstrate a Role for Antimicrobial Prophylaxis

Carlie Stein, BS, Jacob Kelley, MD, Roger Berkow, MD, Matthew A. Kutny, MD

Blood (2012) 120 (21): 4258.

https://doi.org/10.1182/blood.V120.21.4258.4258

Published: 2012

Journal Articles

Novel 1,2,5-Oxadiazole 2-Oxide Derivatives with Analgesic and Fetal Hemoglobin Induced Properties Designed As Drug Candidate to Treat Sickle Cell Disease Symptoms

Jean Leandro Santos, B.Sc., M.Sc., Ph, D, Carolina Lanaro, B.Sc., Ph, D, Sheley Gambero, B.Sc., M.Sc., Rafael Chelucci, B.Sc., Lidia Moreira Lima, B.Sc., M.Sc., Ph, D, Hugo Cerecetto, B.Sc., M.Sc., Ph, D, Mercedes Gonzalez, B.Sc., M.Sc., Ph, D, Fernando Ferreira Costa, MD, PhD, Chung Man Chin, B.Sc., M.Sc., Ph, D

Blood (2011) 118 (21): 2137.

https://doi.org/10.1182/blood.V118.21.2137.2137

Published: 2011

Journal Articles

Novel Hybrids of Hydroxyurea and Thalidomide Based Pharmacophores Induce Fetal Hemoglobin and Block Monocyte Activation

Carolina Lanaro, Ph.D., Carla Franco-Penteado, PhD, Jean Leandro Santos, PhD, Marlene Wade, Shobha Yerigenahally, Sheley Gambero, Lidia Moreira Lima, Chung Man Chin, Abdullah Kutlar, MD, Fernando Ferreira Costa, Ph.D., M.D., Steffen E. Meiler, MD

Blood (2010) 116 (21): 2673.

https://doi.org/10.1182/blood.V116.21.2673.2673

Published: 2010

Journal Articles

Infectious Complications In a Prospective Cohort of Community Based Newly Diagnosed Patients with Chronic Lymphocytic Leukemia (CLL).

Jonathan Moreira, MD, Timothy Call, MD, Kari Rabe, Randy Wendt, Clive S. Zent, MD, Neil E. Kay, MD, Deborah Bowen, Jose Leis, MD, Susan Slager, PhD, Jon Wilson, MD, Tait Shanafelt, MD

Blood (2010) 116 (21): 4610.

https://doi.org/10.1182/blood.V116.21.4610.4610

Published: 2010

Journal Articles

The Hsp90 Inhibitor SNX7081 Restores the Fludarabine Sensitivity of Chronic Lymphocytic Leukemia (CLL) Cells Harbouring Mutations of ATM or TP53

O. Giles Best, BSc, PhD, Stephen P Mulligan, MBBS, PhD, FRACP, FRCPA

Blood (2010) 116 (21): 2473.

https://doi.org/10.1182/blood.V116.21.2473.2473

Published: 2010

Journal Articles

Oral Antibiotic Prophylaxis of Early Infection In Multiple Myeloma: A URCC/ECOG Phase III Study

David H. Vesole, MD, PhD, Martin M Oken, MD, Charles Heckler, Philip R. Greipp, MD, Michael S Katz, BS., MBA, Susanna Jacobus, MS, Gary R Morrow, PhD, MS, On Behalf of the University of Rochester Cancer Center and the Eastern Cooperative Oncology Group

Blood (2010) 116 (21): 3017.

https://doi.org/10.1182/blood.V116.21.3017.3017

Published: 2010

NARROW

Demonstration of the Safety of Post Induction Infusion of Ex-Vivo Expanded Cord Blood Progenitor Cells in Pediatric Patients with Relapsed/Refractory Acute Myelogenous Leukemia

Prophylactic Infusion of Multi-Antigen Specific T-Cell Products to Prevent Complications after T Cell Depleted Allogeneic Stem Cell Transplantation — a Phase I/II Study

Novel Von Willebrand Factor (vWF) Fragment Supports Subcutaneous Administration of Factor VIII: Pharmacokinetic Data from Hemophilia A Mouse Model

A Novel Von Willebrand Factor Fragment Acts As a Chaperone to Prolong the Half-Life of Recombinant Human FVIII (Simoctocog Alfa) in Hemophilia a Dogs and FVIII/VWF Double Knockout Mice

A Novel Method for Highly Sensitive Detection and Isolation of Chimeric Antigen Receptor and Cancer Associated Antigen-Expressing Cells

Pharmacokinetics of Subcutaneously Administered Simoctocog Alfa with Von Willebrand Factor Fragment Candidates in a Minipig Model

Large-Scale, Bioreactor-Generated Expansion of Umbilical Cord Blood Tissue-Derived Mesenchymal Stromal Cells for Clinical Use

TALEN-mediated genetic inactivation of the glucocorticoid receptor in cytomegalovirus-specific T cells

Expanded Access Program of Graspa for Treatment of Patients with Acute Lymphoblastic Leukemia Unable to Receive Other Form of L-Asparaginase - a Status Update (NCT02197650)

Tumor Associated Antigen Reactive Donor T Cells As Elementary Components of Streptamer Isolated Multi-Antigen Specific T Cells

CMV~IMPACT: Results of a Randomized Controlled Trial of Immuno-Prophylactic Adoptive Cellular Therapy following Sibling Donor Allogeneic HSCT

The Impact of Donor HLA Type on Characteristics of CMV-Specific T Cell Products: Experience from Two UK Randomized Trials

Influence Of Steroid Exposure On CMV Specific T Cells Following Allogeneic Stem Cell Transplantation

Geminin Is a Newly Identified Cks1 Interaction Partner and Overexpressed in a Murine Model During Lymphomagenesis

Infectious Complications in Pediatric Patients with AML Demonstrate a Role for Antimicrobial Prophylaxis

Novel 1,2,5-Oxadiazole 2-Oxide Derivatives with Analgesic and Fetal Hemoglobin Induced Properties Designed As Drug Candidate to Treat Sickle Cell Disease Symptoms

Novel Hybrids of Hydroxyurea and Thalidomide Based Pharmacophores Induce Fetal Hemoglobin and Block Monocyte Activation

Infectious Complications In a Prospective Cohort of Community Based Newly Diagnosed Patients with Chronic Lymphocytic Leukemia (CLL).

The Hsp90 Inhibitor SNX7081 Restores the Fludarabine Sensitivity of Chronic Lymphocytic Leukemia (CLL) Cells Harbouring Mutations of ATM or TP53

Oral Antibiotic Prophylaxis of Early Infection In Multiple Myeloma: A URCC/ECOG Phase III Study

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only